PMH1: RIGOROUS CRITERIA FOR TREATMENT RESPONSE DIFFERENTIATED EFFICACY OF OLANZAPINE VERSUS HALOPERIDOL IN PATIENTS WITH SCHIZOPHRENIABJ Kinon; Z Zhao; BL Barber; JA Gilmore · 2001

PMH2: IMPROVEMENT IN QUALITY OF LIFE AND DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIC PATIENTS IS ASSOCIATED WITH ROBUST ACUTE TREATMENT RESPONSE OF OLANZAPINE VERSUS HALOPERIDOLBJ Kinon; Z Zhao; BL Barber; JA Gilmore · 2001

MH1 A ROBUST GLOBAL TREATMENT RESPONSE AVAILABLE TO OLANZAPINE-TREATED PATIENTS IS ASSOCIATED WITH MEANINGFUL IMPROVEMENT IN NEGATIVE SYMPTOMS AND QUALITY OF LIFEBJ Kinon; Z Zhao · 2002